Relay Therapeutics (RLAY) PT Raised to $21 at Citizens on Zovegalisib Top-line Data

May 20, 2026 4:06 AM

Citizens analyst Silvan Turkcan raised the price target on Relay Therapeutics (NASDAQ: RLAY) to $21.00 (from $19.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found